| Literature DB >> 35621981 |
Danijela Štanfel1, Livije Kalogjera2, Sergej V Ryazantsev3, Kristina Hlača1, Elena Y Radtsig4, Rashidov Teimuraz5, Pero Hrabač6.
Abstract
The history of saline nasal irrigation (SNI) is indeed a long one, beginning from the ancient Ayurvedic practices and gaining a foothold in the west at the beginning of the 20th century. Today, there is a growing number of papers covering the effects of SNI, from in vitro studies to randomized clinical trials and literature overviews. Based on the recommendations of most of the European and American professional associations, seawater, alone or in combination with other preparations, has its place in the treatment of numerous conditions of the upper respiratory tract (URT), primarily chronic (rhino)sinusitis, allergic rhinitis, acute URT infections and postoperative recovery. Additionally, taking into account its multiple mechanisms of action and mounting evidence from recent studies, locally applied seawater preparations may have an important role in the prevention of viral and bacterial infections of the URT. In this review we discuss results published in the past years focusing on seawater preparations and their use in clinical and everyday conditions, since such products provide the benefits of additional ions vs. saline, have an excellent safety profile and are recommended by most professional associations in the field of otorhinolaryngology.Entities:
Keywords: nasal irrigation; otorhinolaryngology; seawater; seawater preparation; upper respiratory track
Mesh:
Substances:
Year: 2022 PMID: 35621981 PMCID: PMC9147352 DOI: 10.3390/md20050330
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Major constituents of seawater (mg/dm3).
| Constituent | Dittmar (1940) * [ | Cox (1966) * [ | Riley (1967) * [ | Millero (1996) * [ | Štanfel |
|---|---|---|---|---|---|
| Cl− | 19,805 | - | - | 19,805 | 19,763 |
| Na+ | 11,015 | 11,013 | 11,037 | 11,035 | 12,117 |
| SO42− | 2764 | - | 2776 | 2764 | 2707 |
| Mg2+ | 1327 | 1327 | 1322 | 1314 | 1417 |
| Ca2+ | 418 | 422 | 422 | 422 | 474 |
| K+ | 397 | 408 | 408 | 408 | 443 |
| Br− | 67 | - | 69 | 69 | 63 |
* Seawater sample source. Dittmar (1940): various parts from Atlantic, Indian and Pacific Ocean during the “Challenger” expedition; Cox (1966): locations from the world’s oceans (Atlantic, Indian, Pacific). Detail locations of the samples can be seen in Cox (1996) [10]; Riley (1967): Mediterranean, Irish, Baltic Sea; Millero (1996): Baltic Sea, Baltic-North Sea, Red Sea; Štanfel (2006): Adriatic Sea Kvarner Bay.
Figure 1Proposed mechanism of action of hypertonic seawater preparations locally applied to mucosa of the upper respiratory tract.
Mechanism of action of other constituents in seawater [3,20].
| Constituent | Action |
|---|---|
| Mg2+ | Promotes cell repair and limits inflammation by reducing the eicosanoid metabolism both at the level of the liberation of arachidonic acid and by direct inhibition of the 5-lipoxygenase enzyme. |
| Ca2+ | Acetylcholine and serotonin act as messengers, increasing calcium intake in ciliated cells and thus regulating ciliary beat frequency and synchronization. |
| K+ | Anti-inflammatory action. |
| HCO3− | Reduces mucous viscosity by acting as a buffer. |
Overview of safety and efficacy conclusions from studies with saline and/or saltwater.
| Study | Design | Subjects | Intervention | Safety Conclusions | Other Remarks |
|---|---|---|---|---|---|
| Holmstrom, 1997 [ | Cross-sectional | 45 healthy adults exposed to wood dust | Nasal lavage with Rhinomer force 2, four times a day, every workday. | One increase in allergic symptoms (with concomitant local steroid). One anterior epistaxis and one throat irritation. | At week 3, 88% subjects wanted to continue treatment, and 3 weeks after stopping treatment, 83% wished to start the treatment again. |
| Shoseyov, 1998 [ | RCT | 34 children with chronic sinusitis | Hypertonic (3.5%) vs. isotonic saline, 10 drops, three times daily for 4 weeks. | Three subjects in hypertonic group and one in isotonic group left study because of the burning feeling in the nose and throat. | Burning and itching was more common in hypertonic group, but only during the first 3 to 4 days. After that period, there was no difference between the groups. |
| Rabone, 1999 [ | Crossover trial with 1-year follow-up | 46 woodworkers exposed to wood dust | Gravity fed, home-made unbuffered isotonic saline for 2 months. | Generally safe, no notable adverse events. | The group reported significantly decreased nasal symptoms and over half of subjects continued to use nasal lavage voluntarily after 1 year. |
| Taccariello, 1999 [ | RCT | 40 patients with chronic rhinosinusitis | Traditional alkaline nasal douche vs. a sterile seawater spray, in addition to their regular treatment. | No adverse effects mentioned. | Alkaline nasal douche had a significant effect upon endoscopic appearances, whereas the spray did not; conversely, spray improved quality of life, whereas alkaline douche did not. |
| Bachmann, 2000 [ | RCT | 40 adults with paranasal sinus disease | Isotonic Ems salt solution or isotonic sodium chloride solution nasal irrigation twice daily for 7 days. | No adverse events mentioned in either group. | A slight difference between treatment with Ems salt solution and sodium chloride solution; questionable clinical relevance. |
| Heatley, 2001 [ | Prospective RCT | 150 adults with chronic rhinosinusitis | Nasal saline irrigation with bulb syringe or irrigation pot vs. placebo, daily for 2 weeks. | No significant adverse events; comparable efficacy in all three groups. | More than one-third of subjects reported using less concomitant medication. |
| Rabago, 2002 [ | RCT | 76 adults with acute or chronic rhinosinusitis | Nasal saline irrigation with 150 mL daily per nostril for 6 months vs. no treatment. | Ten side effects, of which 8 were considered as “not significant” and 2 as significant, but affected subjects were still “highly satisfied” with the treatment. | Subjects treated with nasal saline used statistically significantly less antibiotic treatment compared to control group. |
| Garavello, 2003 [ | Prospective RCT | 20 children with allergic rhinitis | Hypertonic saline in 10 subjects, no treatment in 10 subjects; 2.5 mL in each nostril three times daily for 6 weeks. | No patients lost to follow up and no adverse events reported. | Statistically significant decrease in use of oral antihistamines in hypertonic saline group. |
| Lee, 2003 [ | RCT, crossover | 28 healthy adult subjects | Hypertonic (Sinomarin, 3%) or isotonic saline. 10 sprays of both preparations (on different days) in the same nostril. | Complaints of mild prickling sensation after nasal douching with hypertonic seawater. | The effect of the hypertonic solution is probably due to changes in mucus viscoelastic properties. |
| Chkhartishvili, 2004 [ | Case-control open clinical trial | 30 children with allergic rhinitis, acute and chronic bacterial rhinosinusitis and 30 children in control group | “Aqua Maris” seawater solution, either irrigation or 2 drops in nasal cavity 3 times a day from 2 to 4 weeks. | Nasal drops in children up to 2 years of age were well-tolerated, with no complication. No adverse effects mentioned for the irrigation group. | In subjects with bacterial rhinosinusitis, time to relief of symptoms in Aqua Maris group was 7 ± 3.2 days vs. 10 ± 2.4 days in control group. In allergic rhinitis group, Aqua Maris reduced the use of systemic drugs in 7 of 15 patients. |
| Tano, 2004 [ | Prospective trial | 108 healthy army conscripts | 10-week nasal spraying with physiological | Two cases of nose dryness. | There was a mean of 0.7 episodes of upper respiratory tract infection during the spray period, compared with 1.0 episodes during the observation. |
| Wormald, 2004 [ | Prospective, cross-over study | 12 adult subjects | Nasal irrigation with normal saline containing Technetium 99m sulfur colloid | No adverse effects mentioned. | The nasal cavity was well irrigated using three techniques (spray, nebulization, douching). Douching was significantly more effective in penetrating the maxillary sinus and frontal recess. The sphenoid and frontal sinuses were poorly irrigated by all three techniques. |
| Cordray, 2005 [ | Prospective, randomized, single-blind, placebo-controlled | 15 patients with seasonal allergic rhinitis | Intranasal hypertonic dead sea saline spray, intranasal aqueous triamcinolone spray, placebo nasal saline spray for 7 days. | Two subjects withdrew for adverse events (unknown group). | Significant improvements were seen in both active-treatment groups; the corticosteroid spray was the more effective. Dead Sea saline solution can be an effective alternative in mild-to-moderate allergic rhinitis, particularly with respect to nasal and eye symptoms. It improves mucociliary clearance, while Mg cation probably exerts anti-inflammatory effects on the nasal mucosa and on the systemic immune response. |
| Garavello, 2005 [ | Prospective RCT | 44 children with allergic rhinitis | Hypertonic saline vs. no treatment; 3 sprays (50 μL) in each nostril three times daily for 7 weeks. | No adverse events in the treatment group. | Statistically significant decrease in use of oral antihistamines in hypertonic saline group. |
| Kim, 2005 [ | In vitro study | Cell cultures of fully differentiated passage-2 normal human nasal epithelial cells | Cells in the cultures were treated with pure water and with 0.3% (hypotonic), 0.9% (isotonic) and 3% (hypertonic) saline solutions. | In vitro study. | mRNA for major airway mucins analysis and morphologic analysis suggest that pure water damaged epithelial cells, and that only isotonic saline did not affect their morphology. |
| Passali, 2005 [ | RCT | 200 patients with acute viral rhinosinusitis | Atomized nasal douche vs. nasal lavages with isotonic sodium chloride solution. | No adverse effects mentioned. | Atomized nasal douches significantly improved inspiratory and expiratory rhinomanometric resistance and nasal volumes and normalized mucociliary transport time to a physiological level. |
| Wabnitz, 2005 [ | In-vitro study | 8 healthy adult subjects | One application of four sprays of hypertonic (3.0%) saline (one nostril) and isotonic saline (another nostril) in all subjects. | No adverse effects mentioned. | Cell samples from subjects receiving saline solutions. The administration of hypertonic saline results in a significantly faster CBF 5 min (but not 60 min) after administration. |
| Friedman, 2006 [ | Randomized, prospective, double-blind study | 42 adults seeking treatment for chronic rhinosinusitis | Nasal irrigation using hypertonic dead sea salt solution with hypertonic saline. | No adverse effects mentioned. | Both groups had significant improvement after treatment. However, the dead sea salt patients had significantly better symptom relief and showed improved RQLQ(S) scores. |
| Rabago, 2006 [ | Semi-structured, in-depth interviews in a 3-part, multimethod study | 28 subjects with frequent rhinosinusitis and chronic sinonasal symptoms. | Hypertonic saline nasal irrigation. | Side effects including saline drainage, nasal burning and irritation were noted, but not identified as important enough to stop the treatment. | This is a well-tolerated, inexpensive, effective long-term therapy that patients can use at home with minimal training and follow-up. |
| Hauptman, 2007 [ | RCT | 80 adult patients with rhinosinusitis | 1 mL of physiological or hypertonic saline to one nostril. | Increased nasal burning/irritation with hypertonic saline compared to physiological saline. | Buffered physiological saline significantly affected nasal airway patency, whereas buffered hypertonic saline had no effect on nasal patency. |
| Kuzik, 2007 [ | Prospective, randomized, double-blinded, controlled, multicenter trial | 96 infants with viral bronchiolitis | Repeated doses of nebulized 3% hypertonic saline or 0.9% normal saline, in addition to routine therapy. | All participants tolerated therapy without apparent adverse effects, and were eventually discharged after achieving full recovery. | Clinically relevant reduction in length of stay to 2.6 ± 1.9 days in hypertonic saline group, compared with 3.5 ± 2.9 days in the normal saline group. |
| Pynnonen, 2007 [ | Prospective RCT | 127 adults with chronic nasal and sinus symptoms | Irrigation with large volume and low positive pressure or spray for 8 weeks. | Forty-one subjects reported a total of 67 adverse effects. Posttreatment nasal drainage was the most common adverse effect (n = 14) in each group. | Nasal irrigations performed in large volumes and delivered with low positive pressure are more effective than saline sprays for treatment of chronic nasal and sinus symptoms in a community-based population. |
| Karpova, 2008 [ | Open-label parallel-group trial | 84 children with chronic tonsilitis | Experimental group with 64 subjects using Aqua Maris seawater solution, and control group using furacilin solution for 6–8 courses of crypt lavage. | No adverse effects mentioned. | Aqua Maris group showed superior results in terms of odynophagia and dysphagia severity and duration, and hyperaemia and infiltration of the palatine arches. |
| Slapak, 2008 [ | Prospective RCT in parallel groups | 401 children with cold or influenza | Nasal saline irrigation delivered via jet flow or fine spray, or added to standard medication vs. standard medication alone. Applied 6 times daily in acute phase and 3 times daily for 12 weeks thereafter. | At the second visit, only 8.7% patients recorded nasal wash complaints, and at the final visit, this dropped to 2.4%. The other reported complaints were burning, bitter taste and nose bleeding. | The saline treatment was well tolerated. Most complaints appeared in the medium jet group and were associated with the stronger flow of the wash. |
| Süslü, 2009 [ | Prospective RCT | 45 adult subjects after septoplasty | 2.3% buffered hypertonic seawater, buffered isotonic saline, unbuffered isotonic saline; irrigation six times daily for 20 days. | No dropouts; no adverse events mentioned. | Buffered isotonic saline group had worse nasal burning VAS score when compared with both buffered hypertonic and nonbuffered isotonic saline solutions. |
| Ural, 2009 [ | Observational | 132 adult subjects | Control, allergic rhinitis, acute sinusitis and chronic sinusitis groups received two daily doses of hypertonic (3%) or isotonic nasal irrigation for 10 days. | No patients lost to follow up, and no serious side effects or intolerance necessitating cessation of irrigation reported. | Nasal irrigation with isotonic or hypertonic saline can improve mucociliary clearance time in various nasal pathologies. |
| Gelardi, 2009 [ | Randomized pilot study | 20 adult subjects with acute rhinosinusitis | A nasal syringe (10 mL saline solution, 3 times daily for 14 days) or the Lavonase system (250 mL saline solution sac, twice daily for 14 days). | No adverse effects mentioned. | Nasal irrigation with the Lavonase system was found to be more effective in reducing symptoms and decreasing nasal resistances. |
| Li, 2009 [ | RCT | 26 children with allergic rhinitis | Saline irrigation, steroid therapy, saline + steroid therapy groups; twice a day for 8 weeks. | No subjects lost to follow up; no adverse events in saline group. | As adjunctive treatment, nasal saline irrigation alleviates the symptoms and signs of allergic rhinitis in children, and decreases use of topical steroids. |
| Rabago, 2009 [ | Electronic questionnaire | 330 practicing family physicians in Wisconsin, US | Saline nasal irrigation for upper respiratory conditions. | Respondents were not queried directly about perceived safety | Analysis showed that 86.7% of respondents have used the treatment as adjunctive care for conditions including chronic rhinosinusitis (91%), acute bacterial rhinosinusitis (67%), seasonal allergic rhinitis (66%), viral upper respiratory infection (59%), other allergic rhinitis (48%), irritant based congestion (48%) and rhinitis of pregnancy (17%). |
| Cingi, 2010 [ | Prospective | 100 adult subjects with allergic rhinitis | Seawater gel nasal spray in 4-h intervals, two sprays per nostril, from morning till evening for 10 days. | Gel was well-tolerated with no side-effects occurring. | Clinical findings evaluation revealed a statistically significantly decreased rate of nasal congestion and discharge after a 10-day regimen of seawater nasal spray. |
| Culig, 2010 [ | RCT | 60 patients with chronic rhinosinusitis | Isotonic vs. hypertonic seawater spray solution, applied 3–6 times daily. | No adverse events were observed. | Hypertonic solution was statistically significantly superior to the isotonic for all symptoms. |
| Miraglia Del Giudice, 2011 [ | RCT | 40 children with seasonal allergic rhinitis | Nasal lavage with Ischia thermal water vs. isotonic saline. | No significant side effects in either group. | Nasal lavage hyper-mineral chloride-sodium water was effective in children with seasonal allergic rhinitis. |
| Miraglia Del Giudice, 2012 [ | RCT | 34 infants with bronchiolitis | Nebulized normal saline or 3% hypertonic solution in addition to epinephrine and to conventional treatment | Both treatments have an excellent safety profile. | Administration of 3% hypertonic saline is more effective than normal saline in combination with epinephrine in hospitalized children with bronchiolitis. |
| Hermelingmeier, 2012 [ | Systematic review and meta-analysis | 400 subjects of which 86 were children/adolescent and 45 were pregnant | Different treatments. | No adverse events mentioned, however not all studies included safety outcomes. | Saline nasal irrigation using isotonic solution can be recommended as complementary therapy in allergic rhinitis. |
| Satdhabudha, 2012 [ | Prospective RCT | 81 children with allergic rhinitis | Buffered hypertonic (1.25%) saline or isotonic saline; nasal irrigation 2 times daily for 4 weeks. | One subject in each study group experienced nasal burning during the first use. | Satisfaction with nasal irrigation was comparable between groups. |
| Tantilipikorn, 2012 [ | Prospective RCT | 50 adult subjects with chronic rhinosinusitis after endoscopic surgery | Dexpanthenol (Mar Plus) vs. isotonic saline nasal sprays; 4 applications weekly on 1st, 2nd, 4th and 6th postoperative weeks. | Dropout rate was comparable between groups. Three subjects in nasal saline group reported burning sensation. | Product containing seawater (Mar Plus) had better efficacy and comparable safety to nasal saline. |
| Kumar, 2013 [ | RCT | 50 subjects with chronic sinusitis | Hypertonic (3.5%) or isotonic nasal saline; 10 drops, three times a day in both nostrils for 4 weeks. | None of the patients’ groups reported severe burning sensation. Mild burning sensation was reported by 14.3% in isotonic group and by 57.1% in hypertonic group. Moderate burning sensation was reported by 19% of patients in hypertonic group. | Hypertonic saline nasal solution was more efficacious and well tolerated, and it improved quality of life in patients. |
| Chen, 2014 [ | Parallel design with 3 groups | 61 children with allergic rhinitis | Nasal irrigation, intranasal corticosteroid, and combined treatment. | No adverse events reported by subjects. | Nasal irrigation and decreased nasal corticosteroids in combination effected a significant improvement in symptoms and signs, and a significant decrease in the mean eosinophile count in nasal secretions were observed at week 12. |
| Low, 2014 [ | RCT | 74 adult subjects after endoscopic sinus surgery | Normal saline, Ringer’s solution and hypertonic saline group. | No adverse events mentioned. | All groups showed an improvement with treatment in SNOT-20 scores and VAS scores, as well as endoscopic |
| Marchisio, 2014 [ | Questionnaire sent by e-mail | 860 primary care paediatricians | Nasal saline irrigation in preschool children. | 98.3% of the participating physicians evaluated the treatment as effective and safe. | About 40% of physicians expressed doubts about parental compliance, mainly because of a certain difficulty in administration or the supposed invasiveness of the procedure. |
| Nguyen, 2014 [ | Prospective, unblinded, single-arm pilot study | 40 subjects with allergic rhinitis | Large-volume low-pressure saline irrigation twice daily for 8 weeks to the ongoing regiment of nasal corticosteroids. | No adverse events reported. | Saline treatment significantly improved QOL, with no significant changes in nasal flows, pattern use of nasal steroids or adverse events. |
| Pham, 2014 [ | Retrospective cohort study and cross-sectional survey | 144 children with paediatric chronic rhinosinusitis | 6 weeks of once-daily nasal irrigation. | The results of a long-term (median of 48 months) follow-up in 54 participants show treatment as safe and well-tolerated. | Nasal irrigation is effective as a first-line treatment for paediatric chronic rhinosinusitis and subsequent nasal symptoms, and reduces need for FESS and CT imaging. |
| Stoelzel, 2014 [ | RCT | 20 adult subjects with allergic rhinitis | Nasya/Prevalin (a thixotropic nasal gel) vs. isotonic seawater nasal spray; 2 sprays (2 × 0.14 mL) into each nostril. | Three mild AEs were documented in two subjects in the Nasya/Prevalin group (swallowing difficulties, nasal airways obstruction and headache); none related to the application of the investigational product. | There was no difference between the two treatment groups regarding the global assessment of tolerability provided by the investigators or by the subjects. |
| Wang, 2014 [ | Prospective, placebo-controlled RCT | 60 atopic children with acute sinusitis | Standard treatment (including systemic antibiotics, mucolytics and nasal decongestants) with nasal irrigation with normal | No significant side effects were recorded in the isotonic saline irrigation group. | There were significant improvements in mean PRQLQ and nPEFR values for the |
| Alvarez-Puebla, 2015 [ | CT | 35 adults with asthma | Hypertonic saline (5%, administered by nebulizer) or mannitol. | Treatments were well tolerated. | Mannitol and hypertonic saline behaved similarly at sputum induction. |
| Koksal, 2016 [ | Prospective, randomized double-blind trial | 109 children under 2 years of age with acute upper respiratory infection | Saline nasal drops (0.9%), seawater nasal drops (2.3%) and control group (no treatment). | No adverse events mentioned. | No significant difference between saline and seawater groups in terms of nasal congestion, but a significant difference between the control group and these two groups. |
| Bennett, 2015 [ | RCT, open label, cross-over | 12 healthy adults | Hypertonic saline; 2.8% NaCl, 4 mL. | No adverse events mentioned. | Inhaled 2.8% hypertonic saline in normal subjects was associated with a short-lived acceleration of MC, predominately in the central airways. |
| Bonnomet, 2016 [ | Randomized, controlled, blinded, in vitro | Airway epithelial cells obtained from 13 nasal polyp explants | Response (ciliary beat frequency and epithelial wound repair speed) of cells to 3 isotonic nasal irrigation solutions: normal saline 0.9%; non-diluted seawater; and 30% diluted | In vitro study. | Non-diluted seawater obtains the best results on ciliary beat frequency and wound-repair speed vs. normal saline showing a deleterious effect on epithelial cell function. |
| Grasso, 2018 [ | Prospective, controlled clinical trial | 60 patients with allergic rhinitis | Daily, 5-month treatment with isotonic seawater nasal spray enriched with manganese (4 puffs/day). | No adverse events mentioned. | The treatment significantly decreased the number of episodes of acute allergic rhinitis and increased QOL without the adverse effects of the standard care therapy. |
| Bergmann, 2019 [ | Uncontrolled, prospective, longitudinal CT | 136 patients with disorders of nose and paranasal sinuses including 11 pregnant women and one nursing mother | Seawater nasal spray (2.7%). | One adverse event reported (epistaxis). | Over the study period (mean 44 days) statistically significant reductions in 10 out of 12 symptoms was found. Only for parameters “impairment of taste” and “impairment of food intake” was no significant change in symptoms observed. |
| Bogomil’skij, 2019 [ | Uncontrolled, prospective, longitudinal CT | Children aged 2–5 years with acute infectious rhinitis (some with viral comorbidity) | Aqua Maris spray. | None reported. | Rapid regression of symptoms, such as nasal congestion and snoring, a decrease in the amount of nasal discharge by the 3rd day from the start of drug use and normalization of the rhinoscopic findings by the 5th–7th day of treatment. |
| Stobbelaar, 2019 [ | Retrospective study | 104 children up to 2 years of age with bronchiolitis in intensive care unit | Nebulised hypertonic saline. | No adverse events mentioned. | In respiratory syncytial virus positive patients, the use of nebulised hypertonic saline was correlated with a decrease in the duration of respiratory support and the length of stay by factors 0.72 and 0.81, respectively. |
| Craig, 2019 [ | Prospective, randomised, controlled, double-blind, superiority trial | 107 children aged 6 months to 5 years planned to have a nasogastric tube inserted in emergency department | Lidocaine and phenylephrine nasal spray or 0.9% sodium chloride placebo nasal spray, before nasogastric insertion. | Adverse effects occurred in 28% of those who received lidocaine and phenylephrine, and 42% of those who received placebo. | Lidocaine and phenylephrine nasal spray does not reduce procedure-related distress associated with nasogastric tube insertion in young children compared with saline. |
| Perić, 2019 [ | Prospective, randomized study | 30 patients with aspirin-induced chronic rhinosinusitis undergoing endoscopic sinus surgery | Hypertonic (2.3% NaCl) seawater and isotonic 0.9% NaCl. | Nasal discomforts were detected in two patients in hypertonic seawater group and in two patients in the isotonic group. | Significantly lower total symptom score during the 7th, 14th, 21st and 28th days, lower total endoscopic score on the 21st and 28th days, lower nasal obstruction, facial pain/pressure, headache and trouble sleeping, and lower nasal mucosal oedema, nasal secretion and nasal crusting in patients treated by hypertonic seawater. |
| Ramalingam, 2020 [ | Post-hoc secondary analysis of data from the Edinburgh and Lothians Viral Intervention Study | 66 adults with upper respiratory tract infection | The intervention group used hypertonic saline at home and performed nasal irrigation and gargling up to 12 times/day. Control arm participants did not use a specific treatment. | None mentioned. | The duration of illness was shorter in the intervention arm in the subset of patients infected with coronavirus (mean 5.6 vs. 8.1 days). The difference in the duration of blocked nose was −3.1 days, cough −3.3 days and hoarseness of voice −2.9 days in favour of hypertonic saline treatment. |
| Huang, 2021 [ | In vitro | A 3D reconstituted human nasal epithelium model; mixture of human nasal cells isolated from 14 donors. | Seawater preparation (Stérimar Nasal Hygiene), tissue integrity via transepithelial electrical resistance was measured. | In vitro study. | Treatment did not compromise the integrity of the nasal epithelium in vitro but was effective for removal of foreign particles through MCC increase and for enhancing wound repair on nasal mucosa. |
| Jiang, 2021 [ | Multicentre retrospective cohort trial | 144 adult subjects with upper respiratory tract infections | Non-drug supportive treatment vs. supportive treatment and nasal irrigation with sea-salt-derived physiological saline. | No adverse events reported. | Seawater group was statistically significantly superior in terms of nasal congestion, nasal discharge, sleep quality and appetite, but not for cough and fatigue. |
Overview of review articles with saline and/or saltwater.
| Study | Design | Indication(s) | Intervention(s) | Remarks |
|---|---|---|---|---|
| Papsin, 2003 [ | Literature review | Rhinosinusitis, allergic rhinitis, postoperative irrigation, common cold | Nasal irrigation as an adjunct treatment | The procedure has been used safely by both adults and children and has no documented serious adverse effects. Trials indicate that patients treated with nasal irrigation rely less on other medications, and that some postsurgical patients tend to require fewer visits to physicians. Both effects are likely to have desirable economic consequences for patients and the health care system. |
| Brown, 2004 [ | Literature review | (Chronic) sinusitis, sinonasal conditions, rhinitis, postoperative patients | Isotonic and hypertonic saline, buffered/unbuffered solutions, additives such as antibacterial or antifungal agents, home recipes vs. manufactured solutions | Nasal irrigations are an important component in the management of most sinonasal conditions. Authors note a disparity of opinion about the effects of irrigations on ciliary beat frequency and mucociliary clearance and controversy concerning irrigation tonicity and the use of additives to the irrigating solution. |
| Harvey, 2007 [ | Review (Cochrane) | Chronic sinusitis | Randomised controlled trials in which saline was evaluated in comparison with either no treatment, a placebo, as an adjunct to other treatments or against treatments. The comparison of hypertonic versus isotonic solutions. | Saline irrigations are well tolerated. Although minor side effects are common, the beneficial effect of saline appears to outweigh these drawbacks for the majority of patients. The use of topical saline could be included as a treatment adjunct for the symptoms of chronic rhinosinusitis. |
| Kassel, 2010 [ | Review (Cochrane) | Upper respiratory tract infections | RCTs comparing topical nasal saline treatment to other interventions in adults and children with clinically diagnosed acute URTIs. | Three RCTs (618 participants) were included. Most results showed no difference between nasal saline treatment and control. However, there was limited evidence of benefit with nasal saline irrigation in adults. Minor discomfort was not uncommon and 40% of babies did not tolerate nasal saline drops. |
| Zhang, 2008 [ | Review (Cochrane) | Acute bronchiolitis in infants | Nebulized hypertonic saline alone or in conjunction with bronchodilators as an active intervention in infants with acute bronchiolitis. | Current evidence suggests nebulized 3% saline may significantly reduce the length of hospital stay among infants hospitalized with non-severe acute viral bronchiolitis and improve the clinical severity score in both outpatient and inpatient populations. |
| Adappa, 2012 [ | Literature review | Rhinosinusitis | Saline irrigation (hypertonic vs. physiologic), saline spray, antibiotics, topical steroids, topical antifungal treatment, anti IL-5 treatment | Physiologic saline irrigation is beneficial in the treatment of symptoms of CRS. Low-level evidence supports the effectiveness of topical antibiotics in the treatment of CRS. The use of topical antifungals is not supported by the majority of studies. Intranasal steroids are beneficial in the treatment of CRS with nasal polyposis. There is insufficient evidence to demonstrate a clear overall benefit for topical steroids in CRS without nasal polyposis. |
| Chirico, 2014 [ | Literature review | Nasal congestion in infants and children | Nasal saline | The use of isotonic and hypertonic saline solutions is a valuable non-pharmacological treatment for nasal congestion in children, especially by improving mucociliary clearance and reducing the use of medications (antihistamines, decongestants, antibiotics, corticosteroids) during the treatment of URTIs. They are well tolerated and can be recommended for infants. |
| Bastier, 2015 [ | Overview of randomized clinical trials | Different sinonasal pathologies and postoperative care | Different treatments compared to nasal irrigation including rhinocorticoids, antihistamines, buffered, unbuffered, alkaline hypertonic and isotonic saline | Large-volume low-pressure nasal irrigation using undiluted seawater seems, according to the present state of knowledge, to be the most effective protocol. |
| Chong, 2016 [ | Review (Cochrane) | Chronic rhinosinusitis | Studies with follow-up periods of at least three months comparing saline delivered to the nose by any means (douche, irrigation, drops, spray or nebuliser) with placebo, no treatment or other pharmacological interventions | The evidence suggests that there is no benefit from a low-volume nebulised saline spray as opposed to intranasal steroids. There is some benefit from daily, large-volume (150 mL) saline irrigation with a hypertonic solution when compared with placebo. |
| Baron, 2016 [ | Literature review | Bronchiolitis in infants | Hypertonic saline | Authors agree with the AAP guidelines regarding the use of nebulised hypertonic saline to reduce bronchiolitis scores and length of stay for infants with bronchiolitis who are expected to be hospitalised for more than 72 h. |
| Madison, 2016 [ | Literature review | Allergic rhinitis in children | Nasal saline irrigation vs. intranasal corticosteroids | Intranasal steroids are more effective than nasal saline alone in reducing symptoms of allergic rhinitis in children. However, combination therapy further improves symptom reduction. |
| Kanjanawasee, 2018 [ | Systematic search with Ovid MEDLINE, Scopus, PubMed and Google Scholar | Sinonasal diseases, including rhinitis and rhinosinusitis | Hypertonic vs. isotonic saline | Nine studies (740 patients) were included. Hypertonic nasal irrigation brought greater benefits than isotonic treatment in symptom reduction; however, no difference was shown in SNOT-20 improvement. Effects favouring hypertonic solution were greater in patients with rhinitis compared with rhinosinusitis; in patients under the age of 18 years; in saline irrigation using high volume compared with low volume and in saline irrigation with hypertonicity of <3% and hypertonicity of 3–5% compared with hypertonicity of >5%. No major adverse effects were reported. |
| Li, 2019 [ | Systematic review and meta-analysis literature following the PRISMA guidelines | Allergic rhinitis in children | Hypertonic saline nasal irrigation | Hypertonic saline treatment improved patients’ nasal symptom scores and significantly lowered rescue antihistamine use rate. Analyses comparing hypertonic with isotonic saline nasal irrigation found better nasal symptom scores in hypertonic group, although the antihistamine use and adverse-effect rates were similar between groups. |
| King, 2019 [ | Literature review with evidence for each of the indications | Chronic sinusitis, allergic rhinitis, acute URTI | Saline solutions, dependent on the indication studied | Saline nasal irrigation is recommended as an adjunct therapy for common colds/rhinosinusitis, chronic sinusitis, allergic rhinitis and after nasal surgery. It appears to be safe and generally well tolerated, even for children. The use of SNI has the potential to reduce the number of antibiotic prescriptions for acute and chronic sinus infections, and improve outcomes for patients. |